Navigation Links
The Genome Analysis Center Selects Convey to Support Next-Generation Sequencing
Date:1/29/2013

Richardson, TX (PRWEB) January 29, 2013

Convey Computer today announced that The Genome Analysis Center (TGAC), one of seven institutes that receives strategic funding from the U.K.’s Biotechnology and Biological Sciences Research Council (BBSRC), has deployed two Convey HC-1ex hybrid-core systems for advanced genomics research. TGAC, based in the U.K., is an aggressive adopter of advanced sequencing and IT technology.

The two Convey HC-1ex systems are the latest addition to TGAC’s powerful computing infrastructure. By installing hybrid-core Convey HC-1ex systems, TGAC expanded their cluster and ccNUMA-based HPC environment to include leading edge heterogeneous computing capabilities.

“We need to analyze data quickly and precisely, which takes time on clusters,” explained Dr. Mario Caccamo, Deputy Director of TGAC. “We offloaded some of our sequence alignment demand to the Convey hybrid-core systems, because they can handle the alignment algorithms much more efficiently. Using the Convey systems, we are seeing up to 15x acceleration on our computationally intense BWA(1) runs.”

TGAC was part of an international team that recently demonstrated next-generation sequencing could be used effectively to fine map genes in polyploidy wheat. TGAC will leverage Convey’s architecture to accelerate computationally challenging jobs, such as resequencing alignment for wheat and other polyploidy species.

“The initial performance jump is a major improvement,” continued Dr. Caccamo. “We expect to achieve even better performance as we gain experience using the Convey platform.”

Convey’s hybrid-core architecture pairs classic Intel® x86 microprocessors with a coprocessor comprised of FPGAs. Particular algorithms—BWA-based alignment, for example—are optimized and translated into code that’s loadable onto the coprocessor at runtime.

“We’re pleased to be working with BBSRC and TGAC in support of their mission to advance bioscience,” said Dr. George Vacek, Director of Convey Computer’s Life Sciences business unit. “It’s increasingly clear more than one HPC approach is needed to efficiently tackle the full scope of genomics research. Hybrid-core computing has a major role to play, because it accelerates many key bioinformatics applications in an easy to use and economical way.”

About Convey Computer Corporation
Based in Richardson, Texas, Convey Computer breaks power, performance and programmability barriers with the world’s first hybrid-core computer—a system that marries the low cost and simple programming model of a commodity system with the performance of a customized hardware architecture. Using the Convey hybrid-core systems, customers worldwide in industries such as life sciences, research, advanced analytics, and the government/defense are enjoying increased application performance and lower costs of ownership. http://www.conveycomputer.com

(1) Burrows-Wheeler Aligner (BWA) is an efficient program that aligns relatively short nucleotide sequences against a long reference sequence such as the human genome.

For More Information:
Contact Alison Golan, Convey Public Relations, at +1 904.230.3369 or email agolan(at)conveycomputer(dot)com.

All trademarks are the property of their respective owner. ™ and ® denote registered trademarks in the United States and other countries.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10362653.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Whole Genome Sequencing of Triple Negative Breast Cancer Reveals Previously Unreported Mutations
2. Pig genome offers insights into the feistiest of farm animals
3. Researchers unlock disease information hidden in genomes control circuitry
4. In massive genome analysis ENCODE data suggests gene redefinition
5. Millions of DNA switches that power human genomes operating system are discovered
6. Human Genome Decoder and Artificial Life Creator, J. Craig Venter to Speak at "The Atlantic Meets the Pacific"
7. GenScript to Synthesize Yeast Genome with Johns Hopkins Scientists
8. Little known pregnancy disease, Hyperemesis Gravidarum, receives awareness with a $20,000 donation from the H.E.R. Foundation to begin Genome Research at UCLA
9. Two Blades Foundation licenses genome engineering technology to KWS
10. The Human Genome Is Displayed in the Dimension of Time in Web-Based Exhibition by Yonder Biology
11. Webinar Announcement: GenomeSpace: A New Solution for Integrating Genomic Analysis Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):